Method for preparing glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort

Abstract

The present invention belongs to the field of external application, and specifically relates to a preparation method of glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort, collects preparation node characteristic indicators of linear preparation nodes and purified liquid and centrifuge tube characteristic indicators of purification equipment of preparation nodes at all levels, and divides linear preparation nodes into pre-preparation and follow-up preparation nodes; the purification result of the pre-purification equipment of the pre-preparation node is input into the follow-up purification equipment of the follow-up preparation node as its purification raw material; according to the concentration information of the pre-preparation and follow-up purification equipment, combined with the preparation node characteristic indicators and the purified liquid and centrifuge tube characteristic indicators, the amount of purified intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in glucosamine chondroitin cream of the linear preparation node are calculated; and the purification equipment of the linear preparation node is dispatched by this method, so that the purification equipment operates in an optimized state. The present invention reasonably reduces the purified intermediate waste, optimizes the purified liquid to effectively integrate the environmental range products, and brings greater economic benefits to the enterprise.

Description

Technical Field

[0001] The invention belongs to the field of external application, and in particular relates to a method for preparing a glucosamine chondroitin cream for relieving discomfort in bones, muscles and ligaments. Background Art

[0002] Studies have shown that with age, the functions of tissues and organs throughout the body gradually decline, and the loss of glucosamine is greater than the production, resulting in the body's inability to meet its own needs, causing the articular cartilage matrix to soften and lose elasticity, the collagen fiber connective tissue to be destroyed, and the cartilage surface cavities to enlarge, leading to bone hyperplasia and osteoarthritis.

[0003] However, the prior art lacks effective cost control measures in the preparation process of glucosamine chondroitin cream, especially for the multi-stage purification process in the preparation process. The waste and recycling effect of the products of each stage of purification are not high, and the preparation process of glucosamine chondroitin cream cannot be efficiently improved. Summary of the invention

[0004] To achieve the above objectives, this application provides the following technical solutions:

[0005] According to a first aspect of the present invention, the present invention claims a method for preparing a glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort, comprising:

[0006] Collecting the preparation node characteristic index of the linear preparation node and the purified liquid and centrifuge tube characteristic indexes of the purification equipment of each level of preparation nodes, and dividing the linear preparation node into a pre-preparation node and a subsequent preparation node;

[0007] The purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node;

[0008] According to the concentration information of the pre-purification equipment and the subsequent purification equipment, combined with the characteristic index of the preparation node and the characteristic index of the purified liquid and the centrifuge tube, the amount of purified intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in glucosamine chondroitin cream of the linear preparation node are calculated;

[0009] The purification equipment of the linear preparation node is scheduled according to the amount of the purification intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in the amount of glucosamine chondroitin cream, so that the purification equipment operates in an optimized state.

[0010] Furthermore, the collecting of the preparation node characteristic index of the linear preparation node and the purified liquid and centrifuge tube characteristic index of the purification equipment of each level of preparation node also includes:

[0011] The preparation node characteristic index of the linear preparation node at least includes:

[0012] Preparation cycle, preparation power, total preparation volume, intermediate product arrival time, concentration speed;

[0013] The characteristic indicators of the purified solution and the centrifuge tube include at least:

[0014] Type of purification solution, state of purification solution, concentration of purification solution, centrifugal speed of centrifuge tube;

[0015] The types of purified liquid include at least: calcium chloride purified liquid, sodium chloride purified liquid, and chondroitin sulfate purified liquid;

[0016] The state of the purification liquid at least includes: alkaline purification liquid, neutral purification liquid, weak acid purification liquid, and strong acid purification liquid.

[0017] Furthermore, the dividing the linear preparation nodes into pre-preparation nodes and subsequent preparation nodes also includes:

[0018] The linear preparation nodes at least include: a first preparation node, a second preparation node, a third preparation node, and a fourth preparation node;

[0019] The output of the first preparation node is concentrated into a purified raw material for the second preparation node;

[0020] The output of the second preparation node is concentrated into a purified raw material for the third preparation node;

[0021] The output of the third preparation node is concentrated into the purified raw material of the fourth preparation node;

[0022] The first preparation node is a pre-preparation node of the second preparation node, the third preparation node, and the fourth preparation node;

[0023] The second preparation node, the third preparation node, and the fourth preparation node are successor preparation nodes of the first preparation node;

[0024] The second preparation node is a pre-preparation node of the third preparation node and the fourth preparation node;

[0025] The third preparation node and the fourth preparation node are successor preparation nodes of the second preparation node;

[0026] The third preparation node is a preceding preparation node of the fourth preparation node;

[0027] The fourth preparation node is a subsequent preparation node of the third preparation node.

[0028] Furthermore, the purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node, and further includes:

[0029] The purification equipment of the first preparation node is an annual purification equipment with the largest centrifuge tube capacity, which regulates daily raw material delivery and redistributes raw material delivery within the year, stores intermediate products in high order volume cycles for use in low order volume cycles, and is in a low-frequency state in low order volume cycles for alternating operation of subsequent preparation nodes;

[0030] The purification equipment of the second preparation node is a weekly purification equipment. The chondroitin prepared in the low order volume period is replenished by the chondroitin shipped from the purification equipment of the first preparation node. In the high order volume period, the first preparation node replenishes the first proportion of ecological medicine, and the rest is prepared by natural oxidation raw materials.

[0031] The centrifuge tube capacity of the purification equipment of the third preparation node is less than the preset capacity threshold, and the intermediate product quantity of the purification equipment of the second preparation node is relied upon for preparation, and the production of medicines for daily use is undertaken;

[0032] The centrifuge tube capacity of the purification equipment of the fourth preparation node is the smallest, and the low order volume cycle relies on the intermediate product volume of the purification equipment of the third preparation node for preparation, and the high order volume cycle also relies on the environmental product volume for preparation.

[0033] Further, calculating the amount of purified intermediate waste at the linear preparation node also includes:

[0034] Collecting the total amount of preparation of the second preparation node under the neutral purified solution, and calculating the elution dialysis amount of the second neutral purified solution prepared by the second preparation node according to the preparation power and concentration speed of the second preparation node;

[0035] Collecting the total amount of preparation of the third preparation node under the neutral purified solution, and calculating the elution dialysis amount of the third neutral purified solution prepared by the third preparation node according to the preparation power and concentration speed of the third preparation node;

[0036] The amount of purified intermediate waste at the linear preparation node in the neutral purified liquid is calculated based on the elution dialysis volume of the second neutral purified liquid and the elution dialysis volume of the third neutral purified liquid;

[0037] Collecting the total amount of preparation of the second preparation node under weak acid purification solution and strong acid purification solution, and calculating the second medium-low preparation elution dialysis volume of the second preparation node according to the preparation power and concentration speed of the second preparation node;

[0038] The total amount of preparation of the third preparation node under the weak acid purification solution and the strong acid purification solution is collected, and the third medium-low preparation elution dialysis volume of the third preparation node is calculated according to the preparation power and concentration speed of the third preparation node;

[0039] According to the second medium-low preparation elution dialysis volume and the medium-low neutral purification liquid preparation elution dialysis volume, the purification intermediate waste volume of the linear preparation node in the weak acid purification liquid and the strong acid purification liquid is calculated;

[0040] The amount of purified intermediate waste of the linear preparation node in neutral purified liquid and the amount of purified intermediate waste in weak acid purified liquid and strong acid purified liquid is calculated based on the preparation cycle.

[0041] Further, calculating the amount of natural oxidation raw materials of the linear preparation node also includes:

[0042] Collecting the centrifugal rate difference of the first centrifuge tube at the second preparation node when the first purified liquid concentration and the second purified liquid concentration of the strong acid purified liquid are respectively;

[0043] The first full-load processing time of the second preparation node is calculated based on the centrifugal rate difference of the first centrifuge tube and the concentration rate of the second preparation node;

[0044] Determine whether the full-load processing operation status of the second preparation node, the third preparation node, and the fourth preparation node is affected according to the first full-load processing duration and the intermediate product arrival connection time from the first preparation node to the second preparation node;

[0045] collecting the centrifugal rate difference of the second centrifuge tube at the third preparation node when the third purified liquid concentration and the fourth purified liquid concentration of the strong acid purified liquid are obtained;

[0046] The second full-load processing time of the third preparation node is calculated based on the centrifugal rate difference of the second centrifuge tube and the concentration speed of the third preparation node;

[0047] According to the second full-load processing time and the intermediate product arrival connection time from the second preparation node to the third preparation node, determine whether the full-load processing operation status of the third preparation node and the fourth preparation node is affected;

[0048] collecting the centrifugal rate difference of the third centrifuge tube at the fourth preparation node when the fifth purified liquid concentration and the sixth purified liquid concentration of the strong acid purified liquid are obtained;

[0049] The third full-load processing time of the fourth preparation node is calculated based on the centrifugal rate difference of the third centrifuge tube and the concentration speed of the fourth preparation node;

[0050] Based on the third full-load processing duration and the intermediate product arrival connection time from the third preparation node to the fourth preparation node, it is determined whether the full-load processing operation state of the fourth preparation node is affected.

[0051] Further, calculating the increase in glucosamine chondroitin cream corresponding to the linear preparation node also includes:

[0052] The daily increase in the preparation volume is calculated based on the amount of the purified intermediate waste, the preparation power of the third preparation node, and the concentration rate;

[0053] The first preparation volume increase value is calculated based on the peak medical medication period and the daily increase in preparation volume;

[0054] The second preparation amount increase value is calculated based on the environmental product amount, preparation power, and concentration speed of the linear preparation node;

[0055] The first preparation amount increase value and the second preparation amount increase value are added to obtain the glucosamine chondroitin cream increase amount.

[0056] Further, the purification equipment of the linear preparation node is scheduled according to the amount of the purification intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream, so that the purification equipment operates in an optimized state, and further includes:

[0057] When the amount of the intermediate waste from purification, the amount of natural oxidation raw materials and the corresponding increase in the amount of glucosamine chondroitin cream meet the preset conditions, the purification equipment of the second preparation node maintains the first purified liquid concentration during the low order volume cycle to improve resource utilization, and the environment maintains the second purified liquid concentration and below, and the amount of natural oxidation raw materials;

[0058] The purification equipment of the third preparation node is adjusted according to the concentration range of the third purified liquid and the fourth purified liquid during the peak period of medical drug use, and the concentration of the fourth purified liquid is maintained at or below the non-peak medical drug use range, thereby reducing the loss of purification intermediate waste and the loss of secondary resources;

[0059] The purification equipment of the fourth preparation node maintains the fifth purified liquid concentration during the low order volume period to improve resource utilization, and the environment maintains the sixth purified liquid concentration or below to integrate the amount of naturally available products.

[0060] The present invention belongs to the field of external application, and specifically relates to a preparation method of glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort, collects preparation node characteristic indicators of linear preparation nodes and purified liquid and centrifuge tube characteristic indicators of purification equipment of preparation nodes at all levels, and divides linear preparation nodes into pre-preparation and follow-up preparation nodes; the purification result of the pre-purification equipment of the pre-preparation node is input into the follow-up purification equipment of the follow-up preparation node as its purification raw material; according to the concentration information of the pre-preparation and follow-up purification equipment, combined with the preparation node characteristic indicators and the purified liquid and centrifuge tube characteristic indicators, the amount of purified intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in glucosamine chondroitin cream of the linear preparation node are calculated; and the purification equipment of the linear preparation node is dispatched by this method, so that the purification equipment operates in an optimized state. The present invention reasonably reduces the purified intermediate waste, optimizes the purified liquid to effectively integrate the environmental range products, and brings greater economic benefits to the enterprise. BRIEF DESCRIPTION OF THE DRAWINGS

[0061] Figure 1 This is a flowchart of the method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort claimed in the embodiments of the present application. DETAILED DESCRIPTION

[0062] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0063] The terms "first", "second" and "third" in this application are only used for descriptive purposes and cannot be understood as indicating or implying relative importance or implicitly indicating the number of indicated technical features. Therefore, the features defined as "first", "second" and "third" can explicitly or implicitly include at least one of the features. In the description of this application, the meaning of "multiple" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined. All directional indications (such as up, down, left, right, front, back...) in the embodiments of this application are only used to explain the relative position relationship, movement, etc. between the components under a certain specific posture (as shown in the accompanying drawings). If the specific posture changes, the directional indication also changes accordingly. In addition, the terms "including" and "having" and any of their variations are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device that includes a series of steps or modules is not limited to the listed steps or modules, but optionally also includes steps or modules that are not listed, or optionally also includes other steps or modules inherent to these processes, methods, products or devices.

[0064] Reference to "embodiments" herein means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present application. The appearance of the phrase in various locations in the specification does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.

[0065] According to the first embodiment of the present invention, referring to Figure 1 The present invention claims a method for preparing a glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort, comprising:

[0066] Collecting the preparation node characteristic index of the linear preparation node and the purified liquid and centrifuge tube characteristic indexes of the purification equipment of each level of preparation nodes, and dividing the linear preparation node into a pre-preparation node and a subsequent preparation node;

[0067] The purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node;

[0068] According to the concentration information of the pre-purification equipment and the subsequent purification equipment, combined with the characteristic index of the preparation node and the characteristic index of the purified liquid and the centrifuge tube, the amount of purified intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in glucosamine chondroitin cream of the linear preparation node are calculated;

[0069] The purification equipment of the linear preparation node is scheduled according to the amount of the purification intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream, so that the purification equipment operates in an optimized state.

[0070] Among them, in this embodiment, the raw materials of glucosamine chondroitin soothing cream include but are not limited to: glucosamine, chondroitin, sodium hyaluronate, elderberry extract, safflower extract, Panax notoginseng extract, Gastrodia elata extract, olive oil, and rosemary leaf oil.

[0071] Among them, glucosamine and chondroitin: repair and thicken cartilage to avoid pain caused by friction between hard bones;

[0072] Sodium hyaluronate: increases synovial fluid, lubricates joints, and allows joints to move freely;

[0073] Western elderberry extract: repairs damaged bones and prevents bone fragments from entering surrounding tissues, causing redness, swelling, heat and pain;

[0074] Safflower extract and Panax notoginseng extract: promote blood circulation, reduce swelling and relieve pain, and help repair ligaments;

[0075] Olive fruit oil and rosemary leaf oil: have strong penetrating ability to open skin pores, and act as carriers to carry other nutrients for deep penetration, promoting the essence of other nutrients to penetrate deep into the skin, and then directly reach the muscles and joints, accumulate in the affected areas of muscles and joints and play an effective role, absorbing more accurately and faster, improving the penetration and effective utilization rate of each ingredient.

[0076] External application of this product can relieve pain, numbness, stiffness, soreness and other discomforts in joints and muscles. It can quickly help relieve pain and repair injuries during exercise, and prevent sports injuries. Long-term use can achieve a comprehensive maintenance effect on joints, ligaments and muscles.

[0077] At the same time, this product has mild ingredients, does not contain hormones and irritating ingredients, will not irritate the stomach and intestines, and will not affect blood sugar and blood pressure. It can be used safely by a variety of people.

[0078] The product prepared according to the present invention adopts a push-type fully enclosed bottle design, which can effectively block the pollution of external air and dust, ensure that the active ingredients are not oxidized and volatilized, and always maintain the best quality and purity of the product;

[0079] The naturally oxidized raw material refers to the raw material that has undergone oxidation reaction due to contact with ambient air and moisture during the purification and transmission process in each process. The naturally oxidized raw material accelerates the purification process of the unoxidized raw material to a certain extent.

[0080] Furthermore, the collecting of the preparation node characteristic index of the linear preparation node and the purified liquid and centrifuge tube characteristic index of the purification equipment of each level of preparation node also includes:

[0081] The preparation node characteristic index of the linear preparation node at least includes:

[0082] Preparation cycle, preparation power, total preparation volume, intermediate product arrival time, concentration speed;

[0083] The characteristic indicators of the purified solution and the centrifuge tube include at least:

[0084] Type of purification solution, state of purification solution, concentration of purification solution, centrifugal speed of centrifuge tube;

[0085] The types of purified liquid include at least: calcium chloride purified liquid, sodium chloride purified liquid, and chondroitin sulfate purified liquid;

[0086] The state of the purification liquid at least includes: alkaline purification liquid, neutral purification liquid, weak acid purification liquid, and strong acid purification liquid.

[0087] Among them, in this embodiment, the pH value of the alkaline purification liquid is greater than 7, the pH value of the neutral purification liquid is equal to 7, the pH value of the weak acid purification liquid is 6.5-7, and the pH value of the strong acid purification liquid is less than 6.5.

[0088] Furthermore, the dividing the linear preparation nodes into pre-preparation nodes and subsequent preparation nodes also includes:

[0089] The linear preparation nodes at least include: a first preparation node, a second preparation node, a third preparation node, and a fourth preparation node;

[0090] The output of the first preparation node is concentrated into a purified raw material for the second preparation node;

[0091] The output of the second preparation node is concentrated into a purified raw material for the third preparation node;

[0092] The output of the third preparation node is concentrated into the purified raw material of the fourth preparation node;

[0093] The first preparation node is a pre-preparation node of the second preparation node, the third preparation node, and the fourth preparation node;

[0094] The second preparation node, the third preparation node, and the fourth preparation node are successor preparation nodes of the first preparation node;

[0095] The second preparation node is a pre-preparation node of the third preparation node and the fourth preparation node;

[0096] The third preparation node and the fourth preparation node are successor preparation nodes of the second preparation node;

[0097] The third preparation node is a preceding preparation node of the fourth preparation node;

[0098] The fourth preparation node is a subsequent preparation node of the third preparation node.

[0099] Furthermore, the purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node, and further includes:

[0100] The purification equipment of the first preparation node is an annual purification equipment with the largest centrifuge tube capacity, which regulates daily raw material delivery and redistributes raw material delivery within the year, stores intermediate products in high order volume cycles for use in low order volume cycles, and is in a low-frequency state in low order volume cycles for alternating operation of subsequent preparation nodes;

[0101] The purification equipment of the second preparation node is a weekly purification equipment. The chondroitin prepared in the low order volume period is replenished by the chondroitin shipped from the purification equipment of the first preparation node. In the high order volume period, the first preparation node replenishes the first proportion of ecological medicine, and the rest is prepared by natural oxidation raw materials.

[0102] The centrifuge tube capacity of the purification equipment of the third preparation node is less than the preset capacity threshold, and the intermediate product quantity of the purification equipment of the second preparation node is relied upon for preparation, and the production of medicines for daily use is undertaken;

[0103] The centrifuge tube capacity of the purification equipment of the fourth preparation node is the smallest, and the low order volume cycle relies on the intermediate product volume of the purification equipment of the third preparation node for preparation, and the high order volume cycle also relies on the environmental product volume for preparation.

[0104] Further, calculating the amount of purified intermediate waste at the linear preparation node also includes:

[0105] Collecting the total amount of preparation of the second preparation node under the neutral purified solution, and calculating the elution dialysis amount of the second neutral purified solution prepared by the second preparation node according to the preparation power and concentration speed of the second preparation node;

[0106] Collecting the total amount of preparation of the third preparation node under the neutral purified solution, and calculating the elution dialysis amount of the third neutral purified solution prepared by the third preparation node according to the preparation power and concentration speed of the third preparation node;

[0107] The amount of purified intermediate waste at the linear preparation node in the neutral purified liquid is calculated based on the elution dialysis volume of the second neutral purified liquid and the elution dialysis volume of the third neutral purified liquid;

[0108] Collecting the total amount of preparation of the second preparation node under weak acid purification solution and strong acid purification solution, and calculating the second medium-low preparation elution dialysis volume of the second preparation node according to the preparation power and concentration speed of the second preparation node;

[0109] The total amount of preparation of the third preparation node under the weak acid purification solution and the strong acid purification solution is collected, and the third medium-low preparation elution dialysis volume of the third preparation node is calculated according to the preparation power and concentration speed of the third preparation node;

[0110] According to the second medium-low preparation elution dialysis volume and the medium-low neutral purification liquid preparation elution dialysis volume, the purification intermediate waste volume of the linear preparation node in the weak acid purification liquid and the strong acid purification liquid is calculated;

[0111] The amount of purified intermediate waste of the linear preparation node in neutral purified liquid and the amount of purified intermediate waste in weak acid purified liquid and strong acid purified liquid is calculated based on the preparation cycle.

[0112] Further, calculating the amount of natural oxidation raw materials of the linear preparation node also includes:

[0113] Collecting the centrifugal rate difference of the first centrifuge tube at the second preparation node when the first purified liquid concentration and the second purified liquid concentration of the strong acid purified liquid are respectively;

[0114] The first full-load processing time of the second preparation node is calculated based on the centrifugal rate difference of the first centrifuge tube and the concentration rate of the second preparation node;

[0115] Determine whether the full-load processing operation status of the second preparation node, the third preparation node, and the fourth preparation node is affected according to the first full-load processing duration and the intermediate product arrival connection time from the first preparation node to the second preparation node;

[0116] collecting the centrifugal rate difference of the second centrifuge tube at the third preparation node when the third purified liquid concentration and the fourth purified liquid concentration of the strong acid purified liquid are obtained;

[0117] The second full-load processing time of the third preparation node is calculated based on the centrifugal rate difference of the second centrifuge tube and the concentration speed of the third preparation node;

[0118] According to the second full-load processing time and the intermediate product arrival connection time from the second preparation node to the third preparation node, determine whether the full-load processing operation status of the third preparation node and the fourth preparation node is affected;

[0119] collecting the centrifugal rate difference of the third centrifuge tube at the fourth preparation node when the fifth purified liquid concentration and the sixth purified liquid concentration of the strong acid purified liquid are obtained;

[0120] The third full-load processing time of the fourth preparation node is calculated based on the centrifugal rate difference of the third centrifuge tube and the concentration speed of the fourth preparation node;

[0121] Based on the third full-load processing duration and the intermediate product arrival connection time from the third preparation node to the fourth preparation node, it is determined whether the full-load processing operation state of the fourth preparation node is affected.

[0122] Further, calculating the increase in glucosamine chondroitin cream corresponding to the linear preparation node also includes:

[0123] The daily increase in the preparation volume is calculated based on the amount of the purified intermediate waste, the preparation power of the third preparation node, and the concentration rate;

[0124] The first preparation volume increase value is calculated based on the peak medical medication period and the daily increase in preparation volume;

[0125] The second preparation amount increase value is calculated based on the environmental product amount, preparation power, and concentration speed of the linear preparation node;

[0126] The first preparation amount increase value and the second preparation amount increase value are added to obtain the glucosamine chondroitin cream increase amount.

[0127] Further, the purification equipment of the linear preparation node is scheduled according to the amount of the purification intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream, so that the purification equipment operates in an optimized state, and further includes:

[0128] When the amount of the intermediate waste from purification, the amount of natural oxidation raw materials and the corresponding increase in the amount of glucosamine chondroitin cream meet the preset conditions, the purification equipment of the second preparation node maintains the first purified liquid concentration during the low order volume cycle to improve resource utilization, and the environment maintains the second purified liquid concentration and below, and the amount of natural oxidation raw materials;

[0129] The purification equipment of the third preparation node is adjusted according to the concentration range of the third purified liquid and the fourth purified liquid during the peak period of medical drug use, and the concentration of the fourth purified liquid is maintained at or below the non-peak medical drug use range, thereby reducing the loss of purification intermediate waste and the loss of secondary resources;

[0130] The purification equipment of the fourth preparation node maintains the fifth purified liquid concentration during the low order volume period to improve resource utilization, and the environment maintains the sixth purified liquid concentration or below to integrate the amount of naturally available products.

[0131] In the several embodiments provided in the present application, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic, for example, the division of modules is only a logical function division, and there may be other division methods in actual implementation, such as multiple modules or components can be combined or integrated into another system, or some features can be ignored or not executed. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be an indirect coupling or communication connection through some interfaces, devices or modules, which can be electrical, mechanical or other forms.

[0132] In addition, each functional module in each embodiment of the present application can be integrated into a processing module, or each module can exist physically separately, or two or more modules can be integrated into one module. The above integrated modules can be implemented in the form of hardware or in the form of software functional modules. The above is only an implementation method of the present application, and does not limit the patent scope of the present application. Any equivalent structure or equivalent process transformation made using the contents of the specification and drawings of this application, or directly or indirectly used in other related technical fields, are also included in the patent protection scope of the present application.

[0133] The specific implementation methods of the invention are described in detail above, but they are only examples, and the present application is not limited to the specific implementation methods described above. For those skilled in the art, any equivalent modification or substitution of the invention is also within the scope of the present application, and therefore, the equalization, modification, and improvement made without departing from the spirit and principle of the present application should be included in the scope of the present application.

Claims

1. A method for preparing a glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort, characterized in that: include: Collecting preparation node characteristic indicators of linear preparation nodes and purified liquid and centrifuge tube characteristic indicators of purification equipment of each level of preparation nodes, and dividing the linear preparation nodes into pre-preparation nodes and subsequent preparation nodes; The purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node; According to the concentration information of the pre-purification equipment and the subsequent purification equipment, combined with the characteristic index of the preparation node and the characteristic index of the purified liquid and the centrifuge tube, the amount of purified intermediate waste, the amount of natural oxidation raw materials and the corresponding increase in glucosamine chondroitin cream of the linear preparation node are calculated; The purification equipment of the linear preparation node is scheduled according to the amount of the purification intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream, so that the purification equipment operates in an optimized state.

2. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 1, characterized in that: The collecting of the preparation node characteristic index of the linear preparation node and the purified liquid and centrifuge tube characteristic indexes of the purification equipment of each level of preparation nodes also includes: The preparation node characteristic index of the linear preparation node at least includes: Preparation cycle, preparation power, total preparation volume, intermediate product arrival time, concentration speed; The characteristic indicators of the purified solution and the centrifuge tube include at least: Type of purification solution, state of purification solution, concentration of purification solution, centrifugal speed of centrifuge tube; The types of purified liquid include at least: calcium chloride purified liquid, sodium chloride purified liquid, and chondroitin sulfate purified liquid; The state of the purification liquid at least includes: alkaline purification liquid, neutral purification liquid, weak acid purification liquid, and strong acid purification liquid.

3. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 2, characterized in that: The dividing the linear preparation nodes into pre-preparation nodes and subsequent preparation nodes also includes: The linear preparation nodes at least include: a first preparation node, a second preparation node, a third preparation node, and a fourth preparation node; The output of the first preparation node is concentrated into a purified raw material for the second preparation node; The output of the second preparation node is concentrated into a purified raw material for the third preparation node; The output of the third preparation node is concentrated into the purified raw material of the fourth preparation node; The first preparation node is a pre-preparation node of the second preparation node, the third preparation node, and the fourth preparation node; The second preparation node, the third preparation node, and the fourth preparation node are successor preparation nodes of the first preparation node; The second preparation node is a pre-preparation node of the third preparation node and the fourth preparation node; The third preparation node and the fourth preparation node are successor preparation nodes of the second preparation node; The third preparation node is a preceding preparation node of the fourth preparation node; The fourth preparation node is a subsequent preparation node of the third preparation node.

4. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 3, characterized in that: The purification result of the pre-purification equipment of the pre-preparation node is input into the subsequent purification equipment of the subsequent preparation node as the purified raw material of the subsequent preparation node, and further includes: The purification equipment of the first preparation node is an annual purification equipment with the largest centrifuge tube capacity, which regulates daily raw material delivery and redistributes raw material delivery within the year, stores intermediate products in high order volume cycles for use in low order volume cycles, and is in a low-frequency state in low order volume cycles for alternating operation of subsequent preparation nodes; The purification equipment of the second preparation node is a weekly purification equipment. The chondroitin prepared in the low order volume period is replenished by the chondroitin shipped from the purification equipment of the first preparation node. In the high order volume period, the first preparation node replenishes the first proportion of ecological medicine, and the rest is prepared by natural oxidation raw materials. The centrifuge tube capacity of the purification equipment of the third preparation node is less than the preset capacity threshold, and the intermediate product quantity of the purification equipment of the second preparation node is relied upon for preparation, and the production of medicines for daily use is undertaken; The centrifuge tube capacity of the purification equipment of the fourth preparation node is the smallest, and the low order volume cycle relies on the intermediate product volume of the purification equipment of the third preparation node for preparation, and the high order volume cycle also relies on the environmental product volume for preparation.

5. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 4, characterized in that: Calculating the amount of purified intermediate waste at the linear preparation node also includes: Collecting the total amount of preparation of the second preparation node under the neutral purified solution, and calculating the elution dialysis amount of the second neutral purified solution prepared by the second preparation node according to the preparation power and concentration speed of the second preparation node; Collecting the total amount of preparation of the third preparation node under the neutral purified solution, and calculating the elution dialysis amount of the third neutral purified solution prepared by the third preparation node according to the preparation power and concentration speed of the third preparation node; The amount of purified intermediate waste at the linear preparation node in the neutral purified liquid is calculated based on the elution dialysis volume of the second neutral purified liquid and the elution dialysis volume of the third neutral purified liquid; Collecting the total amount of preparation of the second preparation node under weak acid purification solution and strong acid purification solution, and calculating the second medium-low preparation elution dialysis volume of the second preparation node according to the preparation power and concentration speed of the second preparation node; The total amount of preparation of the third preparation node under the weak acid purification solution and the strong acid purification solution is collected, and the third medium-low preparation elution dialysis volume of the third preparation node is calculated according to the preparation power and concentration speed of the third preparation node; According to the second medium-low preparation elution dialysis volume and the medium-low neutral purification liquid preparation elution dialysis volume, the purification intermediate waste volume of the linear preparation node in the weak acid purification liquid and the strong acid purification liquid is calculated; The amount of purified intermediate waste of the linear preparation node in neutral purified liquid and the amount of purified intermediate waste in weak acid purified liquid and strong acid purified liquid is calculated based on the preparation cycle.

6. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 5, characterized in that: Calculating the amount of natural oxidation raw materials for the linear preparation node also includes: Collecting the centrifugal rate difference of the first centrifuge tube at the second preparation node when the first purified liquid concentration and the second purified liquid concentration of the strong acid purified liquid are respectively; The first full-load processing time of the second preparation node is calculated based on the centrifugal rate difference of the first centrifuge tube and the concentration rate of the second preparation node; Determine whether the full-load processing operation status of the second preparation node, the third preparation node, and the fourth preparation node is affected according to the first full-load processing duration and the intermediate product arrival connection time from the first preparation node to the second preparation node; collecting the centrifugal rate difference of the second centrifuge tube at the third preparation node when the third purified liquid concentration and the fourth purified liquid concentration of the strong acid purified liquid are obtained; The second full-load processing time of the third preparation node is calculated based on the centrifugal rate difference of the second centrifuge tube and the concentration speed of the third preparation node; According to the second full-load processing time and the intermediate product arrival connection time from the second preparation node to the third preparation node, determine whether the full-load processing operation status of the third preparation node and the fourth preparation node is affected; collecting the centrifugal rate difference of the third centrifuge tube at the fourth preparation node when the fifth purified liquid concentration and the sixth purified liquid concentration of the strong acid purified liquid are obtained; The third full-load processing time of the fourth preparation node is calculated based on the centrifugal rate difference of the third centrifuge tube and the concentration speed of the fourth preparation node; Based on the third full-load processing duration and the intermediate product arrival connection time from the third preparation node to the fourth preparation node, it is determined whether the full-load processing operation state of the fourth preparation node is affected.

7. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 6, characterized in that: Calculating the increase in glucosamine chondroitin cream corresponding to the linear preparation node also includes: The daily increase in the preparation volume is calculated based on the amount of the purified intermediate waste, the preparation power of the third preparation node, and the concentration rate; The first preparation volume increase value is calculated based on the peak medical medication period and the daily increase in preparation volume; The second preparation amount increase value is calculated based on the environmental product amount, preparation power, and concentration speed of the linear preparation node; The first preparation amount increase value and the second preparation amount increase value are added to obtain the glucosamine chondroitin cream increase amount.

8. The method for preparing the glucosamine chondroitin cream for relieving bone, muscle and ligament discomfort according to claim 7, characterized in that: Scheduling the purification equipment of the linear preparation node according to the amount of the purification intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream so that the purification equipment operates in an optimized state, further comprising: When the amount of the purified intermediate waste, the amount of the natural oxidation raw material and the corresponding increase in the amount of glucosamine chondroitin cream meet the preset conditions, the purification equipment of the second preparation node maintains the concentration of the first purified liquid in a low order volume period; The purification equipment of the third preparation node is adjusted according to the concentration range of the third purified liquid and the fourth purified liquid during the peak period of medical drug use, and the concentration of the fourth purified liquid is maintained at or below the non-peak medical drug use range, thereby reducing the loss of purification intermediate waste and the loss of secondary resources; The purification equipment of the fourth preparation node maintains the fifth purified liquid concentration during the low order volume period.

Images